18/11/2015 - 13:39
SAN FRANCISCO – The investigational combination of ombitasvir, paritaprevir, and ritonavir when given with sofosbuvir (OBV/PTV/r + SOF) for 12 weeks appears to be a highly effective treatment option...
Field of Interest: Gastroentero...
News Feed: Internal Medicine News - Gastroenterology